Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-21

Clinical Trial Update: Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating occurrence of actinic keratosis on the face after cryotherapy followed by aminolevulinic acid photodynamic therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • aminolevulinic acid photodynamic therapy (aminolevulinic acid photodynamic therapy)

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2017-09-21